NEVIRAPINE
| Brand name | VIRAMUNE XR |
|---|---|
| Active ingredient | NEVIRAPINE |
| Strength | 400MG |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | March 2011 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8460704 | March 2029 | use U-1409 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.